Dyslipidemic high-fat diet affects adversely bone metabolism in mice associated with impaired antioxidant capacity

Nutrition

Volumn 27, Issue 2, 2011, Pages 214-220

  Xiao, Ying ^a   Cui, Jue ^a   Li, Ya Xin ^a   Shi, Yong Hui ^a   Wang, Bin ^a   Le, Guo Wei ^a   Wang, Zhou Ping ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Antioxidant; Bone formation; Bone resorption; Hyperlipidemia; IGF 1; Oxidative stress; TNF a

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; COLLAGEN; GLUTATHIONE; GLUTATHIONE DISULFIDE; MESSENGER RNA; PROCOLLAGEN TYPE 1 CARBOXYPROPEPTIDE; SOMATOMEDIN C; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE METABOLISM; CELL SPECIFICITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FEMUR; LIPID DIET; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; BONE AND BONES; BONE RESORPTION; COLLAGEN TYPE I; DIETARY FATS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMUR; HYPERLIPIDEMIAS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS; OXIDATIVE STRESS; PEPTIDES; RANDOM ALLOCATION; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 78650824551     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.11.012     Document Type: Article

References (44)

1. Yang R.L., Li W., Shi Y.H., Le G.W. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 2008, 24:582-588.
2. Parhami F., Garfinkel A., Demer L.L. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000, 20:2346-2348.
3. Bone H.G., Kiel D.P., Lindsay R.S., Lewiecki E.M., Bolognese M.A., Leary E.T., et al. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. J Clin Endocrinol Metab 2007, 92:4671-4677.
4. Wu L.Y., Yang T.C., Kuo S.W., Hsiao C.F., Hung Y.J., Hsieh C.H., et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 2003, 29:317-325.
5. Parhami F., Tintut Y., Beamer W.G., Gharavi N., Goodman W., Demer L.L. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001, 16:182-188.
6. Slim R.M., Toborek M., Watkins B.A., Boissonneault G.A., Hennig B. Susceptibility to hepatic oxidative stress in rabbits fed different animal and plant fats. J Am Coll Nutr 1996, 15:289-294.
7. Sreekumar R., Unnikrishnan J., Fu A., Nygren J., Short K.R., Schimke J., et al. Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am J Physiol Endocrinol Metab 2002, 282:E1055-E1061.
8. Basu S., Michaëlsson K., Olofsson H., Johansson S., Melhus H. association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001, 288:275-279.
9. Isomura H., Fujie K., Shibata K., Inoue N., Iizuka T., Takebe G., et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004, 197:93-100.
10. Muthusami S., Ramachandran I., Muthusamy B., Vasudevan G., Prabhu V., Subramaniam V., et al. Ovariectomy induces oxidative stress and impairs bone antioxidant. Clin Chim Acta 2005, 360:81-86.
11. D'Amelio P., Cristofaro M.A., Tamone C., Morra E., Di Bella S., Isaia G., et al. Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone 2008, 43:1010-1015.
12. Hamada Y., Fujii H., Kitazawa R., Yodoi J., Kitazawa S., Fukagawa M. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Bone 2009, 44:936-941.
13. Garrett I.R., Boyce B.F., Oretto R.O., Bonewald L., Poser J., Mundy G.R. Oxygen derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990, 85:632-639.
14. Lean J.M., Jagger C.J., Kirstein B., Fuller K., Chambers T.J. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 2005, 146:728-735.
15. Kwan Tat S., Padrines M., Théoleyre S., Heymann D., Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004, 15:49-60.
16. Gangoiti M.V., Cortizo A.M., Arnol V., Felice J.I., McCarthy A.D. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells. Eur J Pharmacol 2008, 600:140-147.
17. Cooke G.M. A review of the animal models used to investigate the health benefits of soy isoflavones. J AOAC Int 2006, 89:1215-1227.
18. Rao L.G., Mackinnon E.S., Josse R.G., Murray T.M., Strauss A., Rao A.V. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int 2007, 18:109-115.
19. Kim H.J., Chang E.J., Kim H.M., Lee S.B., Kim H.D., Su Kim G., et al. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 2006, 40:1483-1493.
20. Wohl G.R., Loehrke L., Watkins B.A., Zernicke R.F. Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 1998, 63:74-79.
21. Yang R., Le G., Li A., Zheng J., Shi Y. Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet. Nutrition 2006, 22:1185-1191.
22. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582:67-78.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 1951, 193:265-275.
24. Kobayashi H., Gil-Guzman E., Mahran A.M., Sharma R.K., Nelson D.R., Thomas A.J., et al. Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J Androl 2001, 22:568-574.
25. Scott B.C., Aruoma O.I., Evans P.J., Neill C., Van der Vliet A., Cross C.E., et al. Lipoic and dihydrolipoic acids as antioxidant. A critical evaluation. Free Radic Res 1994, 20:119-133.
26. Young I.S., McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans 2001, 29:358-362.
27. Vaca C.E., Wilhelm J., Harms-Rihsdahl M. Interaction of lipid peroxidation product with DNA. A review. Mutat Res Rev Genet Toxicol 1988, 195:137-149.
28. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
29. Inal M., Altinisik M., Bilgin M.D. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 2002, 20:291-296.
30. Feillet-Coudray C. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 2009, 46:624-632.
31. Parhami F., Jackson S.M., Tintut Y., Le V., Balucan J.P., Territo M., et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999, 14:2067-2078.
32. Takada I., Suzawa M., Matsumoto K., Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann NY Acad Sci 2007, 1116:182-195.
33. Ikeda T., Utsuyama M., Hirokawa K. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 2001, 16:1416-1425.
34. Ha H., Lee J.H., Kim H.N., Kim H.M., Kwak H.B., Lee S., et al. alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol 2006, 176:111-117.
35. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
36. Sims N.A., Clément-Lacroix P., Da Ponte F., Bouali Y., Binart N., Moriggl R., et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of State5. J Clin Invest 2000, 106:1095-1103.
37. McCarthy T.L., Centrella M. Local IGF-I expression and bone formation. Growth Horm IGF Res 2001, 11:213-219.
38. Scacchi M., Pincelli A.I., Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999, 23:260-271.
39. Hinkal G., Donehower L.A. How does suppression of IGF-1 signaling by DNA damage affect aging and longevity?. Mech Ageing Dev 2008, 129:243-253.
40. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 1995, 91:2488-2496.
41. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999, 43:562-571.
42. Kim S.O., Yun S.J., Jung B., Lee E.H., Hahm D.H., Shim I., et al. Hypolipidemic effects of crude extract of adlay seed (Coix Lachrymajobi var. mayuen) in obesity rat fed high fat diet: relations of TNF-a and leptin mRNA expressions and serum lipid levels. Life Sci 2004, 75:1391-1404.
43. Borst S.E., Conover C.F. High-fat diet induces increased tissue expression of TNF-a. Life Sci 2005, 21:56-65.
44. Sheweita S.A., Khoshhal K.I. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 2007, 8:519-525.